Literature DB >> 8659109

Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors.

T Laskus1, L F Wang, J Rakela, H Vargas, A D Pinna, A C Tsamandas, A J Demetris, J Fung.   

Abstract

We studied the outcome of hepatitis C virus (HCV) infection in 14 patients with end-stage HCV-related liver disease who received HCV-positive liver allografts. Viral sequences specific for donor and recipient were established by direct sequencing of PCR products from the NS5 region and by single-strand conformation polymorphism. Within a few months after transplantation the donor strain took over the recipient strain in 8 patients while in 6 patients it was the recipient strain which ultimately prevailed. Donor and recipient were infected by identical genotypes in 6 donor/recipient pairs and by different genotypes in the remaining 8 pairs. Subtype 1b and type 1 (1a + 1b) became the predominant strains in all recipient/donor pairs in which they were present. Patients retaining their own strain were found to have significantly more active liver disease than those infected by the donor strain. We show that HCV superinfection and overtake phenomena occur in humans and suggest that genotypes 1b and 1 (1a + 1b) may possess replicative advantages over other genotypes. Furthermore, we provide evidence of the existence of interference preventing simultaneous continuous infection even by the same genotype strains. The development of active liver disease associated with recipient strain infection and mild or no disease associated with infection from the donor suggests various pathogenic abilities of different HCV strains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8659109     DOI: 10.1006/viro.1996.0297

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication.

Authors:  T Laskus; M Radkowski; L F Wang; M Nowicki; J Rakela
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes.

Authors:  Alejandro Schijman; Rodney Colina; Sergey Mukomolov; Olga Kalinina; Laura García; Shobha Broor; Ajoy Varma Bhupatiraju; Peter Karayiannis; Baldip Khan; Cristina Mogdasy; Juan Cristina
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

Review 3.  The quasispecies of hepatitis C virus and the host immune response.

Authors:  P Farci; J Bukh; R H Purcell
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Hepatitis G virus infection in Amerindians and other Venezuelan high-risk groups.

Authors:  F H Pujol; Y E Khudyakov; M Devesa; M E Cong; C L Loureiro; L Blitz; F Capriles; S Beker; F Liprandi; H A Fields
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Genomic and phylogenetic analysis of hepatitis C virus isolates from argentine patients: a six-year retrospective study.

Authors:  J F Quarleri; B H Robertson; V L Mathet; M Feld; L Espínola; M P Requeijo; O Mandó; G Carballal; J R Oubiña
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 6.  The quasispecies nature and biological implications of the hepatitis C virus.

Authors:  Sarah L Fishman; Andrea D Branch
Journal:  Infect Genet Evol       Date:  2009-08-08       Impact factor: 3.342

7.  Update on the Management of Hepatitis C in Liver Transplant Recipients.

Authors:  David A Bobak; Gopal Yadavalli
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

8.  Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART).

Authors:  Tomasz Laskus; Jeffrey Wilkinson; Roksana Karim; Wendy Mack; Marek Radkowski; Marina deGiacomo; Jonathan Nasseri; Zhi Chen; Jiaao Xu; Andrea Kovacs
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

9.  Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus.

Authors:  A Zibert; W Kraas; H Meisel; G Jung; M Roggendorf
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

10.  Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus.

Authors:  Jin-Won Youn; Yu-Wen Hu; Nancy Tricoche; Wolfram Pfahler; Mohamed Tarek Shata; Marlene Dreux; François-Loic Cosset; Antonella Folgori; Dong-Hun Lee; Betsy Brotman; Alfred M Prince
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.